| 产品名称： | Acremonium chrysogenum (Thirumalachar et Sukapure) Gams |
|---|---|
| 商品货号： | TS209811 |
| Deposited As： | Acremonium chrysogenum (Thirumalachar et Sukapure) Gams, anamorph |
| Strain Designations： | RIT 02/6706 |
| Application： | produces RIT-2214 produces cephalosporin C produces penicillin N adicillin, cephalosporin N, isopenicillin N, synnematin B |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Comments： | autotrophic for lysine and alpha-amino adipic acid |
| Medium： | ATCC® Medium 312: Czapeks agar |
| Growth Conditions： | Temperature: 24.0°C Protocol: plus 1% lysine |
| Subcultivation： | Protocol: plus 1% lysine |
| Name of Depositor： | Takeda Chem. Ind., Ltd. |
| U.S. Patent Number： | |
| Chain of Custody： | ATCC < |
| Isolation： | Mutant of ATCC 11550 |
| References： | Troonan H, et al. New 6-aminopenicillanic acid derivatives. US Patent 3,883,511 dated May 13 1975 Troonen H, et al. RIT 2214, a new biosynthetic penicillin produced by a mutant of Cephalosporium acremonium. J. Antibiot. 29: 1258-1267, 1976. PubMed: 1034629 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Acremonium chrysogenum (Thirumalachar et Sukapure) Gams |
|---|---|
| 商品货号： | TS209811 |
| Deposited As： | Acremonium chrysogenum (Thirumalachar et Sukapure) Gams, anamorph |
| Strain Designations： | RIT 02/6706 |
| Application： | produces RIT-2214 produces cephalosporin C produces penicillin N adicillin, cephalosporin N, isopenicillin N, synnematin B |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Comments： | autotrophic for lysine and alpha-amino adipic acid |
| Medium： | ATCC® Medium 312: Czapeks agar |
| Growth Conditions： | Temperature: 24.0°C Protocol: plus 1% lysine |
| Subcultivation： | Protocol: plus 1% lysine |
| Name of Depositor： | Takeda Chem. Ind., Ltd. |
| U.S. Patent Number： | |
| Chain of Custody： | ATCC < |
| Isolation： | Mutant of ATCC 11550 |
| References： | Troonan H, et al. New 6-aminopenicillanic acid derivatives. US Patent 3,883,511 dated May 13 1975 Troonen H, et al. RIT 2214, a new biosynthetic penicillin produced by a mutant of Cephalosporium acremonium. J. Antibiot. 29: 1258-1267, 1976. PubMed: 1034629 |
